SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-301725
Filing Date
2023-12-22
Accepted
2023-12-22 06:05:34
Documents
13
Period of Report
2023-12-20
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K d454282d8k.htm   iXBRL 8-K 27947
  Complete submission text file 0001193125-23-301725.txt   187929

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA dbvt-20231220.xsd EX-101.SCH 3101
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dbvt-20231220_def.xml EX-101.DEF 13867
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE dbvt-20231220_lab.xml EX-101.LAB 22898
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dbvt-20231220_pre.xml EX-101.PRE 14705
7 EXTRACTED XBRL INSTANCE DOCUMENT d454282d8k_htm.xml XML 5839
Mailing Address 177-181 AVENUE PIERRE BROSSOLETTE MONTROUGE I0 92120
Business Address 177-181 AVENUE PIERRE BROSSOLETTE MONTROUGE I0 92120 33(0)155427878
DBV Technologies S.A. (Filer) CIK: 0001613780 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36697 | Film No.: 231507086
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)